Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Increlex

PharmaCompass

01

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2020 Revenue in Millions : 23

2019 Revenue in Millions : 26

Growth (%) : -13

blank

02

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2021 Revenue in Millions : 19

2020 Revenue in Millions : 23

Growth (%) : -10

blank

03

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Rare Diseases

Currency : USD

2022 Revenue in Millions : 15

2021 Revenue in Millions : 19

Growth (%) : -21

blank

04

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Rare Diseases

Currency : USD

2023 Revenue in Millions : 19

2022 Revenue in Millions : 15

Growth (%) : 24

blank

05

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Rare Diseases and Disorders

Currency : USD

2024 Revenue in Millions : 14

2023 Revenue in Millions : 19

Growth (%) : -24

blank

06

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2015 Revenue in Millions : 14

2014 Revenue in Millions : 22

Growth (%) : 57%

blank

07

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2016 Revenue in Millions : 25

2015 Revenue in Millions : 21

Growth (%) : 20

blank

08

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2017 Revenue in Millions : 28

2016 Revenue in Millions : 29

Growth (%) : -3

blank

09

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2018 Revenue in Millions : 27

2017 Revenue in Millions : 26

Growth (%) : 5%

blank

10

Brand Name : Increlex

Mecasermin

arrow
iPHEX India
Not Confirmed

Brand Name : Increlex

arrow
iPHEX India
Not Confirmed

Mecasermin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2014 Revenue in Millions : 1%

2013 Revenue in Millions :

Growth (%) :

blank